Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:861-866
Published online before print January 13, 2005, doi: 10.1161/01.ATV.0000155987.26583.9b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/4/861    most recent
01.ATV.0000155987.26583.9bv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kempton, C. L.
Right arrow Articles by Monroe, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kempton, C. L.
Right arrow Articles by Monroe, D. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:861.)
© 2005 American Heart Association, Inc.


Thrombosis

Platelet Heterogeneity

Variation in Coagulation Complexes on Platelet Subpopulations

Christine L. Kempton; Maureane Hoffman; Harold R. Roberts; Dougald M. Monroe

From the University of North Carolina, Chapel Hill, Department of Medicine, Division of Hematology-Oncology (C.L.K., H.R.R., D.M.M.); and Durham Veterans Affairs Medical Center (M.H.), Department of Pathology, Carolina Cardiovascular Biology Center, North Carolina.

Correspondence to Dr Dougald M. Monroe, University of North Carolina, 932 Mary Ellen Jones Building, CB 7035, Chapel Hill, NC 27599-7035. E-mail dmonroe{at}med.unc.edu

Objective— Previous work has shown that platelets stimulated with the combination of thrombin and convulxin, a glycoprotein VI agonist, develop 2 populations with different levels of {alpha}-granule factor V bound to the platelet surface. To evaluate whether this phenomenon is restricted to {alpha}-granule components or is a feature that can be generalized to other coagulation factors, we studied the binding of factors V, VIII, IX, and X on the surface of platelets stimulated by convulxin and thrombin.

Methods and Results— The relative amount of factors V, VIII, IX, and X on the surface of platelets stimulated with thrombin or convulxin plus thrombin was measured using flow cytometry. Simultaneous measurements of factor Xa and thrombin generation were obtained and correlated with the binding of coagulation factors on the platelet surface. The binding of factors V, VIII, IX, and X all increased on a subpopulation of platelets when stimulated with the combined agonists. The development of this platelet subpopulation is dependent on convulxin concentration and correlates with increases in factor Xa and thrombin generation.

Conclusions— The development of increased coagulation factor binding to a subpopulation of platelets is not limited to {alpha}-granule components. Convulxin-induced increases in thrombin generation are regulated by the proportion of platelets with increased coagulation factor binding.

Platelets stimulated with convulxin plus thrombin compared with thrombin alone develop a subpopulation with increased surface binding of FV, VIII, IX, and X that is dependent on the concentration of convulxin and is correlated with increases in factor Xa and thrombin generation. These findings suggest that the proportion of platelets in the high-binding subpopulation regulates the degree of thrombin generation in the presence of convulxin.


Key Words: thrombin generation • platelets • glycoprotein VI • COAT • platelet subpopulation




This article has been cited by other articles:


Home page
CirculationHome page
M. Y. Chan, F. Andreotti, and R. C. Becker
Hypercoagulable States in Cardiovascular Disease
Circulation, November 25, 2008; 118(22): 2286 - 2297.
[Full Text] [PDF]


Home page
TraumaHome page
U. Hedner and M. Ezban
Recent advances in clot biology and assessment of clotting
Trauma, October 1, 2008; 10(4): 261 - 270.
[Abstract] [PDF]


Home page
BloodHome page
T.-C. Hsu, K. P. Pratt, and A. R. Thompson
The factor VIII C1 domain contributes to platelet binding
Blood, January 1, 2008; 111(1): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. C.A. Munnix, M. J.E. Kuijpers, J. Auger, C. M.L.G.D. Thomassen, P. Panizzi, M. A.M. van Zandvoort, J. Rosing, P. E. Bock, S. P. Watson, and J. W.M. Heemskerk
Segregation of Platelet Aggregatory and Procoagulant Microdomains in Thrombus Formation: Regulation by Transient Integrin Activation
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2484 - 2490.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. A. Maroney, S. L. Haberichter, P. Friese, M. L. Collins, J. P. Ferrel, G. L. Dale, and A. E. Mast
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets
Blood, March 1, 2007; 109(5): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Jobe, L. Leo, J. S. Eastvold, G. Dickneite, T. L. Ratliff, S. R. Lentz, and J. Di Paola
Role of FcR{gamma} and factor XIIIA in coated platelet formation
Blood, December 15, 2005; 106(13): 4146 - 4151.
[Abstract] [Full Text] [PDF]